The latest news in the Facility
03/01/2012
We are pleased to announce our Illumina MiSeq sequencer has arrived.
01/10/2011
Our FLX instrument have been upgraded to provide the GS FLX+ System, which features a unique combination of long reads, exceptional accuracy and high-throughput, making the system well suited for larger genomic projects.
Advancements in sequencing chemistry, instrumentation and software offer the latest improvements in GS FLX System performance, with read lengths up to 1 kb.
23/02/2011
We are pleased to announce we have recently aquired the Genome Sequencer Junior System from Roche 454. As a complement to our 454 FLX service we now offer a scaled down, faster turnaround service from our 454 Junior platform.
10/03/2010
Carolina Velez has joined the team.
07/04/08
We are pleased to announce we have invested in the Genome Sequencer FLX System from Roche 454. The next generation sequencer has arrived and we forsee a great leap forward for our customers in terms of entire genome sequencing, resequencing and amplicon sequencing.
04/10/07
Information for cosmid DNA sequencing has been added to the website.
18/09/07
Reda Indriulenaite has joined the team.
21/03/07
The S. erythraea Genome Project is complete.
18/12/06
If you want your samples sequenced before the Christmas break the final submission time is Thursday 21st December before 10:30.
The Facility will be closed from 13:30 on Friday 22nd December 2006 and will reopen on Tuesday 2nd January 2007 at 8:00.
25/10/06 DNA Sequencing price reductions announced. For more information take a look at our pricing page.
15/02/06
Nataliya has given birth to her baby son, Alexander.
12/02/06
Anna Efimova has joined the team to cover Nataliya's absence.
03/02/06
Nataliya is temporarily leaving the team for her maternity leave.
22/09/05
Most results are emailed in a Mac BinHex format but can be sent in PC format if requested, please indicate this clearly on your request form.
19/05/05
For large sequencing orders we now offer a DNA preparation service. Please contact John Lester for further information.
|
